Ahmedabad: Sepsivac, the latest innovation by Cadila Pharmaceutical recently received the prestigious Pharma Excellence Award at the Emerging Dimensions in Pharma Excellence e-Summit organised by Express Pharma and HEAL Health Connect Solutions. This honour was awarded to Sepsivac for being one of the most promising drugs in the fight against COVID-19.
The event was attended by leaders from the pharma industry which included prominent pharma Healthcare Professionals who are leading the way for Indian pharma growth the world over.
Addressing the gathering in his keynote Mr. O.P. Singh, President, Sales and Marketing Cadila Pharmaceuticals shared “Sepsivac® is one of our innovations which saves lives in gram negative sepsis. Sepsivac® was developed under NMITLI Program of CSIR (Govt. of India) and is approved for the management of Gram negative sepsis. Sepsivac® strengthens innate immunity of the patient and helps restore natural immune status (homeostasis)”.
Over the year, Cadila Pharmaceuticals Ltd. has been continuously recognized for its all-around efforts to support the community, patient education and coming out with quality medicines. Cadila Pharma was awarded the Exchange4Media Healthcare Marcom award in January for the best social media campaign and was awarded the prestigious Great Place to Work certification. Recently, Cadila Pharma distributed more than 3000 essential kits to families in association with Akshaya Patra Foundation and celebrated Independence Day, by honouring more than 4,000 COVID warriors across the country.
Cadila Pharmaceuticals Ltd. (www.cadilapharma.com) is one of the largest privately-held pharmaceutical companies of India. It has recently concluded and cleared USFDA inspection successfully in February 2020. Over the past six decades, Cadila Pharmaceuticals has been engaged in development and manufacturing of affordable medicines and in making them available for patients across the world. Its innovation-driven drug discovery processes ensure the health and well-being of people around the world.